Seracare Life Sciences Inc (SRLS) - NASDAQ
SRLS is defunct.
  • Feb. 13, 2012, 9:18 AM

    Shares of SeraCare Life Sciences (SRLS) soar 9.5% in premarket action after Linden Capital Partners agrees to buy the firm, but still sit $0.42 off the agreed upon $4 per share deal price.

    | Feb. 13, 2012, 9:18 AM
  • May 3, 2011, 9:46 AM
    Seracare Life Sciences (SRLS +3%) wins a $17.6M contract to maintain the National Institutes of Health's Specimen Repository. SRLS's 2010 revenue was $50.4M.
    | May 3, 2011, 9:46 AM
Company Description
Currently, there's no company description for SRLS.
Sector: Healthcare
Industry: Drugs - Generic
Country: United States